+
Site Tour
Welcome

CONNEXT by Advanced Heart Therapies from Abbott offers personalized educational content, case clubs, expert opinions, and opportunities for networking with peers to raise your learning experience in cardiovascular and stroke prevention therapies.

Please register or login to experience content that is tailored to your needs.
 

Sign in   Register

New ESC/EACTS Guidelines

Advances in TEER and TAVI improving treatment
and care for patients with heart valve disease
 

Learn More

NOTHING EVOKES
SAFETY LIKE TRICLIP.

TriClip TEER is the only tricuspid device proven to reduce risk of heart failure hospitalization and improve quality of life, relative to optimal medical therapy.1
 

EXPLORE NOW

TAVI STRATEGIES FOR PATIENT LIFETIME MANAGEMENT

Expert interview on lifetime patient management for longer life expectancy
 

Watch Now

CARDIAC SURGERY ADVANCED WEBINAR SERIES

A webinar series featuring expert insights on the latest advancements in aortic and mitral valve replacement
 

Watch Now

REAL WORLD EXPERIENCE WITH NAVITOR™ VISION*

Increased experience with the Navitor Vision Valve supports low permanent pacemaker implantation at 30 days2
 

Explore Now

join the community   •   REGISTER TO RECEIVE THE LATEST UPDATES

Connext TV
MitraClip Symposium | PCR LV

Visit our dedicated channel for the latest hot topics, videos, animations and interviews.

learn more
Connext Hub
The Amulet IDE Trial

Download the latest materials including emerging and established information on cardiovascular conditions and stroke prevention technologies.

learn more
Connext Live
TAVI webinar - key learnings in TAVI

Hear from experts at the home of Abbott's live events.

learn more

New and Trending

The Standard of Caring For TR

Nothing Evokes Safety Like TriClip

EACTS Symposium 2025

Learn from Leading Experts at the EACTS Symposium 2025

TAVI strategies for patient lifetime management

Explore index TAVI strategies for patient lifetime management

TAVI Symposium | PCR LV 2025

Optimizing long-term outcomes through thoughtful index valve selection

MitraClip Symposium | PCR LV

Mitral regurgitation: from guidelines to clinical practice

EXPAND G4 clinical data release | PCR LV 2025

2-year outcomes from the EXPAND G4 study presented at PCR LV 2025 by F. De Marco

bRIGHT interview with X. Freixa | PCR LV 2025

Interview with X. Freixa on bRIGHT procedural clipping strategy presented at PCR LV 2025

Tendyne expanded clinical study | PCR LV 2025

5-year outcomes of TMVR for severe symptomatic mitral regurgitation presented at PCR LV 2025 by A. Duncan

TAVI webinar - key learnings in TAVI

TAVI in low and intermediate risk patients: what do we know

TriClip Symposium | PCR LV 2025

From Innovation to Intervention: Optimizing Procedural Techniques in T-TEER 

bRIGHT clinical data release | PCR LV 2025

bRIGHT procedural clipping strategy presented at PCR LV 2025 by X. Freixa

Navitor Low PPI & Radiopaque Markers

Real-World Experience: 10.6% New PPI With Navitor Vision* Valve After 20 Procedures

Navitor Active-Sealing Cuff

Navitor™ Vision* Valve: PVL sealing by unique design

Advances in Imaging | Tricuspid Focus

AV Valves Summit 2025 
R. Estevez, N. Karam, F. Sarnago, P. Vriesendorp

From Experience to the Future | Tricuspid Focus

AV Valves Summit 2025 
Lior Zoref, F. Maisano, M. Sitges, G. Nickenig, RS von Bardeleben

Therapies

Valvular Diseases

Mitral Valve DiseaseAortic Valve DiseaseTricuspid Valvle DiseaseParavalvular Leak

Stroke

Stroke Associated with PFOStroke Associated with Atrial Fibrillation

Congenital Heart Diseases

Patent Ductus Arteriosus

Heart Failure

Heart Failure Disease

SOLUTIONS

MITRACLIP™ TEER

TRICLIP™ TEER

TENDYNE™ TMVR

NAVITOR™ TAVI

EPIC™ MAX

EPIC™ PLUS

MECHANICAL HEART VALVES

REPAIR PRODUCTS

AMPLATZER™ AMULET™ LAAO

AMPLATZER™ TALISMAN™ PFO

AMPLATZER™ DUCT™OCCLUDER

AMPLATZER™ PICCOLO OCCLUDER

AMPLATZER™ VALVULAR PLUG III

CARDIOMEMS™ HF SYSTEM

Connext
Live

REGISTER FOR OUR
VIRTUAL VENUE

Hear expert opinions first hand and collaborate on best practices.

Find out more

References

*Labeled as Navitor™ and Navitor Titan™ with Vision Technology

  1. Kar S, Makkar RR, Whisenant BK, et al. Two-year outcomes of transcatheter edge-to-edge repair for severe tricuspid regurgitation: The TRILUMINATE Pivotal Randomized Trial. Circulation. March 30, 2025. doi:10.1161/CIRCULATIONAHA.125.074536
  2. Real World Experience with the Navitor Valve in US Patients. S. Garcia on behalf of the Navitor Implanters enrolling in the STS/ACC TVT Registry. Presented at New York Valves, June 25-27, 2025, New York, NY.

© Abbott 2026. All rights reserved. 9-EH-5-14584-01 02-2026 REV N

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline